Acasti Pharma Inc.
ACST
Clasificación en acciones
#29742
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Precio por acción
$0.4256834
Última sincronización: 2023-03-27
Capitalización bursátil
$18.99M
Cambio (1 día)
3.08%
Cambio (1 año)
-87.02%
País
CA
Comercio Acasti Pharma Inc. (ACST)
Categoría
Healthcare
Ganancias de Acasti Pharma Inc. (ACST)
Ganancias en Jun 2026 TTM: $-21.92M
Secondo gli ultimi rapporti finanziari di Acasti Pharma Inc., gli utili attuali della società sono $-21.92M. Nel 2024, la società ha registrato un utile di $-14.69M, un aumento con respecto a agli utili del 2023, che erano di $-51.97M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Acasti Pharma Inc. desde 2010 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $-21.92M | 71.69% |
| 2025 | $-12.77M | -13.06% |
| 2024 | $-14.69M | -71.74% |
| 2023 | $-51.97M | 396.52% |
| 2022 | $-10.47M | -46.81% |
| 2021 | $-19.68M | -22.87% |
| 2020 | $-25.51M | -11.81% |
| 2019 | $-28.93M | 124.01% |
| 2018 | $-12.91M | 176.67% |
| 2016 | $-4.67M | 341.30% |
| 2015 | $-1.06M | -88.77% |
| 2014 | $-9.42M | 43.86% |
| 2013 | $-6.55M | -1.01% |
| 2012 | $-6.61M | 0.00% |
| 2011 | 0.00 | -100.00% |
| 2010 | $-1.45M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $5.27B | -24,164.32% |
US
|
|
| $-3.09B | 13,983.03% |
US
|
|
| $-4.02B | 18,222.06% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -8,998.95% |
NL
|
